Search results
Results from the WOW.Com Content Network
Hemolytic disease of the newborn (anti-Rhc) can range from a mild to a severe disease. It is the third most common cause of severe HDN. Rh disease is the most common and hemolytic disease of the newborn (anti-Kell) is the second most common cause of severe HDN. It occurs more commonly in women who are Rh D negative.
Congenital hemolytic anemia (CHA) is a diverse group of rare hereditary conditions marked by decreased life expectancy and premature removal of erythrocytes from blood flow. Defects in erythrocyte membrane proteins and red cell enzyme metabolism , as well as changes at the level of erythrocyte precursors, lead to impaired bone marrow ...
The below tests are often useful in cases of hemolytic disease of the newborn but are not required for treatment of all newborns. Hgb — the infant's hemoglobin should be tested from cord blood. [6] Reticulocyte count — Reticulocytes are elevated when the infant is producing more red blood cells in response to anemia. [6]
Hemolytic anemia accounts for 5% of all existing anemias. [2] It has numerous possible consequences, ranging from general symptoms to life-threatening systemic effects. [2] The general classification of hemolytic anemia is either intrinsic or extrinsic. [3] Treatment depends on the type and cause of the hemolytic anemia. [2]
Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...
Hgb - the infant's hemoglobin should be tested from cord blood. [5] Reticulocyte count - Reticulocytes are elevated when the infant is producing more blood to combat anemia. [5] A rise in the reticulocyte count can mean that an infant may not need additional transfusions. [18]
The first treatment for Rh disease was an exchange transfusion invented by Wiener [24] and later refined by Dr. Harry Wallerstein. [25] Approximately 50,000 infants received this treatment. However, this could only treat the disease after it took root and did not do anything to prevent the disease.
Its overall phenotype resembles a combination of autoimmune hemolytic anemia and immune thrombocytopenic purpura. [1] [4] [5] Autoimmune hemolytic anemia is a condition in which the red blood cells that normally carry oxygen are destroyed by an autoimmune process. Immune thrombocytopenic purpura is a condition in which platelets are destroyed ...